Solara Active Pharma Sciences Limited — Others, 16-05-2025: Copy of Newspaper Publication

Solara Active Pharma Sciences Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company reported consolidated revenue from operations of Rs. 273 Cr for the quarter and Rs. 1,283.76 Cr for the year, with a net loss after tax of Rs. 2.10 Cr for the quarter and a modest net profit of Rs. 0.54 Cr for the year. The Board also discussed a potential demerger of its CRAMS and Polymers businesses into a separate listed entity, signaling a strategic move to unlock value for shareholders.